Transcriptional regulation of the HMGA1 gene by octamer-binding proteins Oct-1 and Oct-2

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Chiefari, Eusebio ^a   Arcidiacono, Biagio ^a   Possidente, Katiuscia ^a   Iiritano, Stefania ^a   Ventura, Valeria ^a   Pandolfo, Rosantony ^a   Brunetti, Francesco Saverio ^a   Greco, Manfredi ^a   Foti, Daniela ^a   Brunetti, Antonio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP A1B PROTEIN; OCTAMER TRANSCRIPTION FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 2;

ARTICLE; AUTOREGULATION; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HMGA1 GENE; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN BINDING; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

BASE SEQUENCE; BINDING SITES; CELL NUCLEUS; GENE EXPRESSION REGULATION; HELA CELLS; HEP G2 CELLS; HMGA1A PROTEIN; HUMANS; NUCLEOTIDE MOTIFS; OCTAMER TRANSCRIPTION FACTOR-1; OCTAMER TRANSCRIPTION FACTOR-2; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECEPTOR, INSULIN; TRANSCRIPTION, GENETIC;

EID: 84893177137     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083969     Document Type: Article

References (41)

1. Johnson KR, Lehn DA, Reeves R (1989) Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y. Mol Cell Biol 9: 2114-2123. (Pubitemid 19117812)
2. Friedmann M, Holth LT, Zoghbi HY, Reeves R (1993) Organization, inducible-expression, and chromosome localization of the human HMG-I(Y) nonhistone protein gene. Nucleic Acids Res 21: 4259-4267. (Pubitemid 23279015)
3. Bustin M, Reeves R (1996) High-mobility group proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol 54: 35-100.
4. Thanos D, Maniatis T (1995) Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83: 1091-1100. (Pubitemid 26007801)
5. Reeves R (2001) Molecular biology of HMGA proteins: hubs of nuclear function. Gene 277: 63-81.
6. Reeves R, Beckerbauer L (2002) HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochim Biophys Acta 1519: 13-29.
7. Sgarra R, Rustighi A, Tessari MA, Di Bernardo J, Altamura S, et al. (2004) Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer. FEBS Lett 574: 1-8. (Pubitemid 39200885)
8. Cleynen I, Van de Ven WJ (2008) The HMGA proteins: a myriad of functions (Review). Int J Oncol 32: 289-305.
9. Fedele M, Fusco A (2010) HMGA and cancer. Biochim Biophys Acta 1799: 48-54.
10. Foti D, Iuliano R, Chiefari E, Brunetti A (2003) A nucleoprotein complex containing Sp1, C/EBPβ, and HMGI-Y controls human insulin receptor gene transcription. Mol Cell Biol 23: 2720-2732. (Pubitemid 36403073)
11. Foti D, Chiefari E, Fedele M, Iuliano R, Brunetti L, et al. (2005) Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. Nat Med 11: 765-773. (Pubitemid 41021209)
12. Chiefari E, Paonessa F, Iiritano S, Le Pera I, Palmieri D et al. (2009) The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis. BMC Biol 7: 24 doi:10.1186/1741-7007-7-24.
13. Chiefari E, Nevolo MT, Arcidiacono B, Maurizio E, Nocera A, et al. (2012) HMGA1 is a novel downstream nuclear target of the insulin receptor signaling pathway. Sci Rep 2 251. doi: 10.1038/srep00251.
14. Iiritano S, Chiefari E, Ventura V, Arcidiacono B, Possidente K et al . (2012) The HMGA1-IGF-I/IGFBP system: a novel pathway for modulating glucose uptake. Mol Endocrinol 26: 1578-1589.
15. Chiefari E, Iiritano S, Paonessa F, Le Pera I, Arcidiacono B, et al. (2010) Pseudogene-mediated posttranscriptional silencing of HMGA1 can result in insulin resistance and type 2 diabetes. Nat Commun 1 40. doi: 10.1038/ncomms1040. doi:10.1186/1741-7007-7-24.
16. Chiefari E, Tanyolaç S, Paonessa F, Pullinger CR, Capula C, et al. (2011) Functional variants of the HMGA1 gene and type 2 diabetes mellitus. JAMA 305: 903-912.
17. Liu L, Ding H, Wang HR, Xu YJ, Cui GL, et al. (2012) Polymorphism of HMGA1 is associated with increased risk of type 2 diabetes among Chinese individuals. Diabetologia 55: 1685-1688.
18. Chiefari E, Tanyolaç S, Iiritano S, Sciacqua A, Capula C et al. (2013) A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components. Sci Rep 3 1491. doi: 10.1038/srep01491.
19. Pullinger CR, Goldfine ID, Tanyolaç S, Movsesyan I, Faynboym M, et al. (2013) Evidences that an HMGA1 gene variant associates with type 2 diabetes, BMI, and HDL cholesterol in an Hispanic-American population. Metab Syndr Relat Disord (Epub ahead of print). PubMed: 24148075.
20. Ogram SA, Reeves R (1995) Differential regulation of a multipromoter gene. Selective 12-O-tetradecanoylphorbol-13-acetate induction of a single transcription start site in the HMG-I/Y gene. J Biol Chem 270: 14235-14242.
21. Asman DC, Takimoto K, Pitot HC, Dunn TJ, Lindahl R (1993) Organization and characterization of the rat class 3 aldehyde dehydrogenase gene. J Biol Chem 268:12530-12536. (Pubitemid 23182412)
22. Cleynen I, Huysmans C, Sasazuki T, Shirasawa S, Van de Ven W, et al. (2007) Transcriptional control of the human high mobility group A1 gene: basal and oncogenic Ras-regulated expression. Cancer Res 67: 4620-4629. (Pubitemid 46910166)
23. Staudt LM, Lenardo MJ (1991) Immunoglobulin gene transcription. Annu Rev Immunol 9: 373-398.
24. Zhao FQ (2013) Octamer-binding transcription factors: genomics and functions. Front Biosci (Landmark Ed) 18: 1051-1071.
25. Brunetti A, Foti D, Goldfine ID (1993) Identification of unique nuclear regulatory proteins for the insulin receptor gene, which appear during myocyte and adipocyte differentiation. J Clin Invest 92: 1288-1295. (Pubitemid 23273904)
26. Brunetti A, Manfioletti G, Chiefari E, Goldfine ID, Fotic D (2001) Transcriptional regulation of the insulin receptor by the high mobility group protein HMGI(Y). FASEB J 15: 492-500. (Pubitemid 32141441)
27. nd ed Cold Spring Harbor, NY Cold Spring Harbor Laboratory Press.
28. Thanos D, Maniatis T (1992) The high mobility group protein HMGI(Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene. Cell 71: 777-789.
29. Tanaka M, Herr W (1990) Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell 60: 375-386.
30. Paonessa F, Foti D, Costa V, Chiefari E, Brunetti G, et al. (2006) Activator protein-2 overexpression accounts for increased insulin receptor expression in human breast cancer. Cancer Res 66: 5085-5093. (Pubitemid 43844930)
31. Costa V, Paonessa F, Chiefari E, Palaia L, Brunetti G, et al. (2008) The insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-γ (PPARγ) and thiazolidinedione-PPARγ agonists. Endocr Relat Cancer 15: 325-335. (Pubitemid 351449750)
32. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, et al. (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21: 2933-42. (Pubitemid 40916416)
33. Abdulkadir SA, Casolaro V, Tai AK, Thanos D, Ono SJ (1998) High mobility group I/Y protein functions as a specific cofactor for Oct-2A: mapping of interaction domains. J Leukoc Biol 64: 681-691. (Pubitemid 28511990)
34. Schaffner W (1989) How do different transcription factors binding the same DNA sequence sort out their jobs? Trends Genet 5: 37-39.
35. Tanaka M, Lai JS, Herr W (1992) Promoter-selective activation domains in Oct-1 and Oct-2 direct differential activation of an snRNA and mRNA promoter. Cell 68: 755-767.
36. Cleary MA, Stern S, Tanaka M, Herr W (1993) Differential positive control by Oct-1 and Oct-2: activation of a transcriptionally silent motif through Oct-1 and VP16 corecruitment. Genes Dev 7: 72-83. (Pubitemid 23071201)
37. Darville MI, Terryn S, Eizirik DL (2004) An octamer motif is required for activation of the inducible nitric oxide synthase promoter in pancreatic β-cells. Endocrinology 145: 1130-1136. (Pubitemid 38280992)
38. Ng MC, Lam VK, Tam CH, Chan AW, So WY, et al. (2010) Association of the POU class 2 homeobox 1 gene (POU2F1) with susceptibility to Type 2 diabetes in Chinese populations. Diabet Med 27: 1443-1449.
39. Wang P, Wang Q, Sun J, Wu J, Li H, et al. (2009) POU homeodomain protein Oct-1 functions as a sensor for cyclic AMP. J Biol Chem 284: 26456-26465.
40. Wang P, Jin T (2010) Oct-1 functions as a sensor for metabolic and stress signals. Islets 2: 46-48.
41. Bianconcini A, Lupo A, Capone S, Quadro L, Monti M, et al. (2009) Transcriptional activity of the murine retinol-binding protein gene is regulated by a multiprotein complex containing HMGA1, p54 nrb/NonO, protein-associated splicing factor (PSF) and steroidogenic factor 1 (SF1)/liver receptor homologue 1 (LRH-1). Int J Biochem Cell Biol 41: 2189-2203.